|
|
|
By Aurea M. Flores, Ph.D. | When it comes to selecting a new clinical trial technology, consultant Aurea Flores, Ph.D. suggests stakeholders and end users explore options and make recommendations based on a modified version of the Delphi Method. |
|
|
|
| There Is More To CDMS Than EDC | Article | By Richard Young, Veeva Systems, Inc. | EDC alone cannot solve the data challenges posed by hybrid digital trials. Discover how this role can be taken on by also aggregating, cleaning, and providing user-based access to all trial data. |
|
|
| eCOA 101: Why Choose ePRO Vs. Paper | Infographic | Signant Health | ePRO solutions enhance data quality, operational efficiency, and patient-centricity in clinical trials by allowing patients to report outcomes digitally instead of using pen and paper. |
|
|
| Evidence Generation Evolved | Article | By Colin Weller, Medable | Explore how innovative strategies are cutting clinical trial times in half and accelerating the delivery of life-saving treatments. |
|
|
| Lessons On The Use Of RWE In Regulatory Submissions | Article | By Martin Roessner, David Brown, and Sheng Feng, Ph.D.（冯胜）, Parexel International | Read along as authors share their most significant lessons, offering guidance on how to harness the full potential of RWE to drive innovation and efficiency in drug development. |
|
|
|
|
| Why You Should Expect More From Your IRT/RTSM | E-Book | Perceptive Inc | Explore the need for advanced capabilities beyond basic RTSM and the importance of having experienced teams behind IRT solutions to navigate complexities and ensure successful trial execution. |
|
|
.png){kind=logo}
